A new frontier in pharmacology: The endoplasmic reticulum as a regulated export pathway in health and disease

Expert Opinion on Therapeutic Targets

Volumn 5, Issue 2, 2001, Pages 165-176

  Moyer, Bryan D ^a   Balch, William E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

aggregation; Alzheimer's disease; cargo selection; chemical chaperone; cystic fibrosis; degradation; disease; emphysema; endoplasmic reticulum; protein folding; regulated ER export

Indexed keywords

EID: 0242326155     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.5.2.165     Document Type: Review

References (72)

1. ARIDOR M, BALCH WE: Integration of endoplasmic reticulum signaling in health and disease. Nat. Med. (1999) 5:745-751.
2. ARIDOR M, HANNAN LA: Traffic jam: a compendium of human diseases that affect intracellular transport processes. Traffic (2000) 1:836-851.
3. RIORDAN JR, ROMMENS JM, KEREM B et al.: Identifica tion of the cystic fibrosis gene: cloning and characteri zation of complementary DNA [published erratum appears in Science 1989 Sep 29;245(4925):1437]. Science (1989) 245:1066-1073.
4. KOPITO RR: Biosynthesis and degradation of CFTR. Physiol. Rev. (1999) 79:S167-173.
5. QU D, TECKMAN JH, PERLMUTTER DH: Alpha 1-antitrypsin deficiency associated liver disease. J. Gastroenterol. Hepatol. (1997) 12:404-416.
6. SIFERS RN, FINEGOLD MJ, WOO SLC: Molecular biology and genetics of alpha1-antitrypsin deficiency. Sem. Liver Disease (1992) 12:301-310.
7. KUHN L: Iron overload: molecular clues to its cause. TrendsBiochem. Sci. (1999) 24:164-166.
8. SHELNESS GS, INGRAM MF, HUANG XF, DELOZIER JA: Apolipoprotein B in the rough endoplasmic reticulum: translation, translocation and the initiation of lipoprotein assembly. J. Nutr. (1999) 129:456S-462S.
9. JOHNSTON JA, WARD CL, KOPITO RR: Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. (1998) 143:1883-1898.
10. TABARY O, ESCOTTE S, COUETIL JP et al: Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells. Am. J. Pathol. (1999) 155:473-481.
11. DIMANGO E, RATNER AJ, BRYAN R, TABIBI S, PRINCE A: Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J. Clin. Invest. (1998) 101:2598-2605.
12. KIM PS, ARVAN P: Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr. Rev. (1998) 19:173-202.
13. PROCKOP DJ, KIVIRIKKO KI: Collagens: molecular biology, diseases and potentials for therapy. Ann. Rev. Biochem. (1995) 64:403-434.
14. HODES M, PRATT V, DLOUHYS: Genetics of Perlizaeus-Merzbacher disease. Devel. Neurosci. (1993) 15:383-394.
15. GOW A, LAZZARINI RA: A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nature Gen. (1996) 13:422-428.
16. GRIFFITHS I, KLUGMANN M, ANDERSON T etal.: Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (1998) 280:1610-1613.
17. DE JONGHE P, TIMMERMAN V, NELIS E, MARTIN J, VAN BROECKHOVEN C: Charcot-Marie-Tooth disease and related peripheral neuropathies. J. PNS (1997) 2:370-387.
18. D'URSO D, PRIOR R, GREINER-PETTER R, GABREELS-FESTEN AAWM, MULLER HW: Overloaded endoplasmic reticulum-golgi compartments, a possible pathome-chanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J. Neurosci. (1998) 18:731-740.
19. SELKOE DJ: The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. (1998) 8:447-453.
20. DE STROOPER B, SAFTIG P, CRASESSAERTS K et al.: Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature (1998) 391:387-390.
21. DE STROOPER B, BEULLEN M, CONTRERAS B et al.: Phosphorylation, subcellular localization and membrane orientation of the Alzheimer's disease-associated persenilins. J. Biol. Chem. (1997) 272:3590-3598.
22. CULVENOR JD, MAHER F, EVIN G et al.: Alzheimer's disease associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-golgi intermediate compartment. J. Neurosci. Res. (1997) 49:719-731.
23. HAASS C, MANDELKOW E: Proeolysis by presenilins and the renassance of tau. Trends Cell Biol. (1999) 9:241-244.
24. COOK DG, FORMAN MS, SUNG JC et al: Alzheimer's ABeta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nature Med. (1997) 3:1021-1023.
25. MATTSON MP, GUO Q, FURUKAWA K, PEDERSEN WA: Presenilins, the endoplasmic reticulum and neuronal apoptosis in Alzheimer's disease. J. Neurochem. (1998) 70:1-14.
26. PLOEGH HL: Viral strategies of immune evasion. Science (1998) 280:248-253.
27. MARGOTTIN F, BOUR SP, DURAND H et al: A novel human WD protein, h-betaTrCP, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell (1998) 1:565-574.
28. DOEDENS JR, GIDDINGS TH, KIRKEGAARD K: Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis.J. Virol. (1997) 71:9054-9064.
29. LORD JM, ROBERTS LM: Toxin entry: retrograde transport through the secretory pathway. J. Cell Biol. (1998) 140:733-736.
30. SIMPSON JC, DASCHER C, ROBERTS LM, LORD JM, BALCH WE: Ricin cytotoxicity is sensitive to recyclingbetween the endoplasmic reticulum and the Golgi complex. J. Biol. Chem. (1995) 270:20078-20083.
31. SANDVIG K, GARRED O, PRYDZ K et al: Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature (1992) 358:510-512.
32. SATO S, WARD CL, KROUSE ME, WINE JJ, KOPITO RR: Glycerol reverse the misfoldingphenotype of the most common cystic fibrosis mutation. J. Biol. Chem. (1996) 271:635-638.
33. BROWN CR, HONG-BROWN LQ, BIWERSI J, VERKMAN AS, WELCH WJ: Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones (1996) 1:117-125.
34. QU BH, STRICKLAND EH, THOMAS PJ: Localization and suppression of a kinetic defect in cystic fibrosis transmembrane conductance regulator folding. J. Biol. Chem. (1997) 272:15739-15744.
35. BEBOK Z, VENGLARIK CJ, PANCZEL Z et al.: Activation of DeltaF508 CFTR in an epithelial monolayer. Am. J. Physiol. (1998) 275:C599-607.
36. MORELLO JP, SALAHPOUR A, LAPERRIERE A et al.: Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants [see comments]. J. Clin. Invest. (2000) 105:887-895.
37. TAMARAPPOO BK, VERKMAN AS: Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J. Clin. Invest. (1998) 101:2257-2267.
38. BURROWS JA, WILLIS LK, PERLMUTTER DH: Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc. Natl. Acad. Sci. USA (2000) 97:1796-1801.
39. ZHOUZ, GONG Q, JANUARY CT: Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. pharmacological and temperature effects. J. Biol. Chem. (1999) 274:31123-31126.
40. LOO TW, CLARKE DM: Correction of defective protein kinesis of human p-glycoprotein mutants by substrates and modulators. J. Biol. Chem. (1997) 272:709-712.
41. RUBENSTEIN RC, ZEITLIN PL: Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR [see comments]. Am. J. Physiol. Cell Physiol. (2000) 278:C259-267.
42. RUBENSTEIN RC, ZEITLIN PL: A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restora-tionof nasal epithelial CFTR function. Am. J. Respir. Crit. Care Med. (1998) 157:484-490.
43. RUBENSTEIN RC, EGAN ME, ZEITLIN PL: In vitropharma-cologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J. Clin. Invest .(1997) 100:2457-2465.
44. JIANG C, FANG SL, XIAO YF et al.: Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualin. Am. J. Physiol. (1998) 275:C171-178.
45. LOO MA, JENSEN TJ, CUI L et al.: Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J. (1998) 17:6879-6887.
46. MEACHAM GC, PATTERSON C, ZHANG W, YOUNGER JM, CYR DM: The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat. Cell Biol. (2001) 3:100-105.
47. MALIDE D, YEWDELL JW, BENNINK JR, CUSHMAN SW: The export of major histocompatibility complex class I molecules from the endoplasmic reticulum of rat brown adipose cells is acutely stimulated by insulin. Mol. Biol. Cell (2001) 12:101-114.
48. MACINTYRE S, SAMOLS D, DAILEY P: Two carboxyles-terases bind C-reactive protein within the endoplasmic reticulum and regulate its secretion during the acute phase response. J. Biol. Chem. (1994) 269:24496-24503.
49. RIVERA VM, WANG X, WARDWELL S et al: Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum [see comments]. Science (2000) 287:826-830.
50. LEE HC, KIM SJ, KIM KS, SHIN HC, YOON JW: Remission in models of Type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature (2000) 408:483-488.
51. MATLACK KE, MOTHES W, RAPOPORT TA: Protein translocation: tunnel vision. Cell (1998) 92:381-390.
52. TROMBETTA ES, HELENIUS A: Lectins as chaperones in glycoprotein folding. Curr. Opin. Struct. Biol. (1998) 8:587-592.
53. LIU Y, CHOUDHURY P, CABRAL CM, SIFERS RN: Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J. Biol. Chem. (1999) 274:5861-5867.
54. HAMMOND C, HELENIUS A: Quality control in the secretory pathway. Curr. Opin. Cell Biol. (1995) 7:523-529.
55. BARLOWE C: COPII and selective export from the endoplasmic reticulum. Biochim. Biophys. Acta (1998) 1404:67-76.
56. KUEHN MJ, HERRMANN M, SCHEKMAN R: COPII-cargo interactions direct protein sorting into ER-derived transport vesicles. Nature (1998) 391:187-190.
57. ARIDOR M, WEISSMAN J, BANNYKH S, NOUFFER C, BALCH WE: Cargo selection by the COPII budding machinery during export from the endoplasmic reticulum.J. Cell Biol. (1998) 141:61-70.
58. BANNYKH SI, ROWE T, BALCH WE: Organization of endoplasmic reticulum export complexes. J. Cell Biol. (1996) 135:19-35.
59. NISHIMURA N, BALCH WE: A di-acidic signal required for selective export from the endoplasmic reticulum. Science (1997) 277:556-558.
60. BAKER EK, COLLEY NJ, ZUKER CS: The cyclophilin homolog NinaA functions as a chaperone, forming a stable complex in vivo with its protein target rhodopsin. EMBOJ. (1994) 13:4886-4895.
61. KUWANA T, PETERSON PA, KARLSSON L: Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation. PNAS USA (1998) 95:1056-1061.
62. SOMMERT, WOLFDH: Endoplasmic reticulum degrada tion: reverse protein flow of no return. FASEBJ. (1997) 11:1227-1233.
63. BRODSKY JL, MCCRACKEN AA: ER-associated and proteasome-mediated protein degradation: how two topologically restricted events came together. Trends Cell Biol. (1997) 7:151-156.
64. PLEMPER RK, WOLF DH: Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem. Sci. (1999) 24:266-270.
65. CIECHANOVER A, ORIAN A, SCHWARTZ AL: Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays (2000) 22:442-451.
66. KOPITO RR: Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. (2000) 10:524-530.
67. BROWN MS, YE J, RAWSON RB, GOLDSTEIN JL: Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell (2000) 100:391-398.
68. TRAVERS KJ, PATIL CK, WODICKA Let al.: Functionaland genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell (2000) 101:249-258.
69. CHAPMAN R, SIDRAUSKI C, WALTER P: Intracellular signaling from the endoplasmic reticulum to the nucleus. Ann. Rev. Cell Dev. Biol. (1998) 14:459-485.
70. HARDING HP, ZHANG Y, RON D: Protein translation and folding are coupled byanendoplasmic-reticulum-resident kinase [published erratum appears in Nature 1999 Mar 4;398(6722):90] [see comments]. Nature (1999) 397:271-274.
71. PAHL HL, BAEUERLE PA: Endoplasmic reticulum induced signal transduction and gene expression. Trends Cell Biol. (1997) 7:50-55.
72. PAHL HL, BAEUERLE PA: The ER-overload response: activation of NF-κB. Trends Cell Biol. (1997) 22:63-67.